Teladoc Health (Teladoc Health) Interest Expense : $-17 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Teladoc Health Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Teladoc Health's interest expense for the three months ended in Dec. 2023 was $ -6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-17 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Teladoc Health's Operating Income for the three months ended in Dec. 2023 was $ -30 Mil. Teladoc Health's Interest Expense for the three months ended in Dec. 2023 was $ -6 Mil. Teladoc Health did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Teladoc Health Interest Expense Historical Data

The historical data trend for Teladoc Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teladoc Health Interest Expense Chart

Teladoc Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-29.36

-59.95

-81.14

-21.94

-22.28

Teladoc Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-4.59	-	-5.84	-5.65	-5.54

Teladoc Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17 Mil.

Teladoc Health (NYSE:TDOC) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Teladoc Health's Interest Expense for the three months ended in Dec. 2023 was $-6 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-30 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $1,582 Mil.

Teladoc Health's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Teladoc Health did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Teladoc Health (Teladoc Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Teladoc Health Inc (NYSE:TDOC) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

TDOC:Mexico 4LL:Germany T2DH34:Brazil

Address

2 Manhattanville Road, Suite 203, Purchase, NY, USA, 10577

Website

https://www.teladochealth.com

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.

Executives

Daniel Trencher	officer: SVP Corporate Strategy	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Vidya Raman-tangella	officer: Chief Medical Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Karen L Daniel	director	2801 80TH STREET, KENOSHA WI 53141
Jason N Gorevic	director, officer: President & CEO
Andrew Turitz	officer: SVP - Business Development	C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Stephany Verstraete	officer: Chief Marketing Officer	C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Adam C Vandervoort	officer: Chief Legal Officer, Secretary	485 MADISON AVENUE, NEW YORK NY 10022
Mala Murthy	officer: Chief Financial Officer	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Richard J Napolitano	officer: Chief Accounting Officer	MSCI INC., 7 WORLD TRADE CENTER, 250 GREENWICH STREET, 49TH FLOOR, NEW YORK NY 10007
Arnnon Geshuri	officer: Chief Human Resources Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Laizer Kornwasser	officer: PRESIDENT, ENTERPRISE GROWTH	100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417
Michael Willem Waters	officer: CHIEF OPERATING OFFICER	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Jason Eric Evans	director	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Claus Torp Jensen	officer: Chief Innovation Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Sandra L Fenwick	director	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577